rhodioloside has been researched along with carbon tetrachloride in 2 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (carbon tetrachloride) | Trials (carbon tetrachloride) | Recent Studies (post-2010) (carbon tetrachloride) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 8,804 | 11 | 2,582 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, X; Jiang, R; Kuang, G; Liu, X; Ma, L; Wan, J; Zhang, X | 1 |
| Ping, J; Xu, LM; Ye, QN; Zhao, CQ | 1 |
2 other study(ies) available for rhodioloside and carbon tetrachloride
| Article | Year |
|---|---|
Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation.
Topics: Animals; Carbon Tetrachloride; Caspases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytokines; Down-Regulation; Glucosides; Inflammasomes; Liver; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Phenols; Protective Agents | 2020 |
[Study on mechanism of salidroside against liver fibrosis by regulating CXCL16].
Topics: Animals; Carbon Tetrachloride; Chemokine CXCL16; Glucosides; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Mice; Phenols | 2021 |